Literature DB >> 19683463

Reversible neurological deficit after foam sclerotherapy.

K Hartmann1, L Harms, M Simon.   

Abstract

A 37-year-old male was treated with 9 ml of 3% polidocanol foam, and he immediately reported photopsiae lasting a few minutes, though without migraine. Two hours after sclerotherapy, the patient developed speech disturbance for a few minutes. A pathological examination revealed nothing except a patent foramen ovale (PFO). Given the contrast between the high prevalence of PFO in general population and the extremely low incidence of neurological deficits after foam sclerotherapy, these deficits may only arise due to as-yet-unknown aetiology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19683463     DOI: 10.1016/j.ejvs.2009.06.022

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  2 in total

1.  Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO).

Authors:  Sun Young Choi; Jong Yun Won; Kyung Ah Kim; Do Yun Lee; Kwang-Hun Lee
Journal:  Eur Radiol       Date:  2010-08-26       Impact factor: 5.315

Review 2.  Visual loss following sclerotherapy for varicose veins.

Authors:  James Chiung Yoong Leong; Nicholas Robert Johnston
Journal:  BMJ Case Rep       Date:  2011-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.